NANOMEDTRIX LLC
Coralville, IA · Biotech · Private
Mesoporous silica nanoparticles (MSN) for intravesical delivery of chemotherapeutic agents to bladder cancer tumors
nanomedtrix.com →- Grants
- $4.4M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 3 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles | $295,240 | |
| Federal grant | Department of Health and Human Services · Phase I · Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles | $1,043,125 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles | $2,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles | $956,875 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1901 | SYNSHARK LLC | — | $213K |
| 1902 | Blank! The Musical LLC | — | $550K |
| 1903 | SEQLL, LLC | — | $2.5M |
| 1904 | NANOMEDTRIX LLC | — | — |
| 1905 | Hemispherian AS | — | $108K |
| 1906 | MBF THERAPEUTICS, INC. | — | $2.0M |
| 1907 | GRANNUS THERAPEUTICS, INC. | — | $1.8M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Pharmaceutical Composition With Nanoparticle-based Drug Delivery Combined With Non-invasive Radiographic Monitoring Modelgranted
- Pharmaceutical Composition With Nanoparticle-based Drug Delivery Combined With Non-invasive Radiographic Monitoring Modelgranted
- Porous Nanocarriers For The Monitoring And Treatment Of Bladder Cancerapplication
- Porous Nanocarriers For The Monitoring And Treatment Of Bladder Cancergranted
- Porous Nanocarriers For The Monitoring And Treatment Of Bladder Cancerapplication
- Porous Nanocarriers For The Monitoring And Treatment Of Bladder Cancerapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.